Stephen D. Ryder
Nottingham Digestive Diseases Centre
University of Nottingham
Nottingham
United Kingdom
NG7 2UH
Papers:
4K-6
WHEN AND WHERE IN THE TREATMENT PATHWAY IS IT APPROPRIATE TO USE NEW DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C?